Company:  MARINUS PHARMACEUTICALS I ... (MRNS)
Form Type:  SC 13G/A
Filing Date:  2/14/2020 
CIK:  0001267813 
Address:  5 RADNOR CORPORATE CENTER SUITE 500
100 MATSONFORD RD
 
City, State, Zip:  RADNOR, Pennsylvania 19087 
Telephone:  484-801-4670 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$2.50  
Change: 
-0.06 (-2.34%)  
Trade Time: 
Feb 28  
Market Cap: 
$216.78M
Trade MRNS now with 

© 2020  
Description of Business
We are a clinical stage pharmaceutical company focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Our clinical stage product candidate, ganaxolone, is a positive allosteric modulator of GABAA being developed in three different dose forms: intravenous (IV), oral capsule and oral liquid. The multiple dose forms are intended to maximize the therapeutic range of ganaxolone for adult and pediatric patient populations, in acute and chronic care, and both in-patient and self-administered settings. Ganaxolone exhibits anti-seizure, anti-depression and anti-anxiety actions via its effects on synaptic and extrasynaptic GABAA receptors.
Register and access this filing in:     
  FORM SC 13G/A